Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672038 | SCV000797097 | likely pathogenic | Nephropathic cystinosis | 2018-01-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000672038 | SCV004215229 | pathogenic | Nephropathic cystinosis | 2022-02-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003765488 | SCV004571039 | pathogenic | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2023-11-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln108Argfs*10) in the CTNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTNS are known to be pathogenic (PMID: 9537412, 27102039). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with cystinosis (PMID: 28238446, 35513889). ClinVar contains an entry for this variant (Variation ID: 253205). For these reasons, this variant has been classified as Pathogenic. |
IUMS Hospital Medical Genetics Lab, |
RCV000239704 | SCV000297854 | pathogenic | Cystinosis | no assertion criteria provided | clinical testing | ||
Rasad Genetic Department, |
RCV000672038 | SCV002099450 | pathogenic | Nephropathic cystinosis | 2020-01-01 | no assertion criteria provided | clinical testing |